Korean ECM heads for six year high with chunky IPOs

South Korea’s IPO market is on track for a surge of issuance, as Doosan Bobcat and Samsung BioLogics prepare to list in the fourth quarter. Mid-caps are also lining up to float, giving a fillip to the country’s equity capital markets. Jonathan Breen reports.